BIOMAT Database Logo BIOMAT Database Logo

The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma. 1977

N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
April 1974, Cancer,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
[High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
September 1980, Harefuah,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.
December 1977, Cancer treatment reports,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
[Platelet function and high-dose methotrexate treatment with citrovorum factor rescue].
August 1984, Onkologie,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Daily profiles of plasma phenylalanine and tyrosine in patients with osteogenic sarcoma during treatment with high-dose methotrexate-citrovorum rescue.
January 1989, Medical and pediatric oncology,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
January 1980, Therapeutic drug monitoring,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
May 1975, The New England journal of medicine,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue.
June 1985, Cancer,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
February 1978, Cancer treatment reports,
N Jaffe, and D Traggis, and J R Cassady, and R M Filler, and H Watts, and E Frei
Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
January 1983, Pediatric pharmacology (New York, N.Y.),
Copied contents to your clipboard!